Erratum to: ‘Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance’

Sabrina J. Merat, Camille Bru, Dorien van de Berg, Richard Molenkamp, Alexander W. Tarr, Sylvie Koekkoek, Neeltje A. Kootstra, Maria Prins, Jonathan Ball, Arjen Q. Bakker, Menno D. de Jong, Hergen Spits, Tim Beaumont, Janke Schinkel

Research output: Other contribution

Abstract

It has come to our attention that there is an error in Fig. 2A and consequently the Graphical Abstract of our manuscript. During the production process, the colors used in the legend to the pie chart were incorrectly assigned, so that those representing AR3 and AR4 were reversed. Please see the corrected Fig. 2 and Graphical Abstract below. We apologize for any inconvenience caused.
Original languageEnglish
Number of pages2
Edition4
Volume73
DOIs
Publication statusPublished - 1 Oct 2020
Externally publishedYes

Publication series

NameJournal of Hepatology
PublisherElsevier B.V.
ISSN (Print)0168-8278

Fingerprint

Dive into the research topics of 'Erratum to: ‘Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance’'. Together they form a unique fingerprint.

Cite this